OPINION
JOHN R. GIBSON, Circuit Judge.
Relator Jeff Walburn appeals the district court’s dismissal of his
qui tam
action brought under the False Claims Act, 31 U.S.C. §§ 3729-33. Walburn’s suit alleges
that defendant Lockheed Martin altered and submitted false documents for compensation and incentive payments under its agreement with the United States to operate the Portsmouth Gaseous Diffusion Plant in Piketon, Ohio. The district court dismissed the action under the first-to-file bar of 31 U.S.C. § 3730(b)(5). We affirm the dismissal.
Relator Walburn alleges that he was employed as a security officer at the Portsmouth Plant, patrolling areas of the plant used to enrich uranium and store nuclear materials. The plant is owned by the United States and leased by the United States Enrichment Corporation, an entity created by Congress under the Energy Policy Act of 1992, 42 U.S.C. § 2297 (repealed). Lockheed enriches uranium for commercial and national defense purposes at the plant pursuant to a contract with the United States. Walburn alleges that federal law required Lockheed to maintain accreditation with the Department of Energy in order to conduct these operations. Beginning in 1981, employees at the plant were required to wear thermoluminescent dosimeters that would mechanically measure individual doses of radiation exposure. As a condition of its Department of Energy accreditation, Lockheed was required to keep records of the dosimeter readings together with a record of each employee’s dosage. Walburn alleges that after he was exposed to gases at the plant in 1994, Lockheed changed the recorded reading of his dosimeter, and that this was just one of at least 400 to 600 such changes Lockheed made to employees’ dosage readings each year. He alleges that Lockheed perpetrated this fraud in order to maintain its Department of Energy accreditation and continue to receive payments from the United States under its contract to operate the Portsmouth Plant.
On July 23, 1996, Walburn filed a multicount action against Lockheed seeking compensatory and punitive damages as a result of his exposure to gases at the Portsmouth Plant. Walburn sought relief in federal court on theories of (1) breach of contract, (2) civil rights violations under 42 U.S.C. §• 1983, (3) intentional tort, and (4) loss of consortium. On July 16, 1997, the district court entered an order dismissing the action. On May 25, 2000, Walburn filed the present
qui tarn
action under seal with the United States Department of Justice, alleging that Lockheed’s falsification of the dosage readings violated § 3729(a) of the False Claims Act.
See
31 U.S.C. § 3730(b)(2). Following an investigation into Walburn’s allegations, the United States declined to intervene.
Id.;
31 U.S.C. § 3730(b)(4)(B). Walburn elected to prosecute the action himself, and on November 12, 2002, the action was unsealed.
See
31 U.S.C. § 3730(b)(4)(B). Reviewing Lockheed’s motion to dismiss, the district court concluded that Walburn’s allegations were encompassed by the allegations in
United States ex rel Kenneth Brooks v. Lockheed Martin Corp., et al.,
No. Civ. L-00-1088, 2005 WL 841997, filed in the District of Maryland on April 24, 2000. Because the
Brooks
complaint was filed first, the district court dismissed Walburn’s action for lack of subject matter jurisdiction under the first-to-file bar of 31 U.S.C. § 3730(b)(5).
United States ex rel. Walburn v. Lockheed Martin Corp.,
312 F.Supp.2d 936, 940-41 (S.D.Ohio 2004). Walburn appeals the dismissal. 28 U.S.C. § 1291.
I.
We review de novo the dismissal of an action under the False Claims Act for lack of subject matter jurisdiction.
United States ex rel. McKenzie v. Bell-South Telecommunications, Inc.,
123 F.3d 935, 938 (6th Cir.1997);
see also United
States ex rel Lujan v. Hughes Aircraft Co.,
243 F.3d 1181, 1187 (9th Cir.2001);
Minnesota Ass’n of Nurse Anesthetists v. Allina Health System Corp.,
276 F.3d 1032, 1040 (8th Cir.2002). Because federal courts are courts of limited jurisdiction, the plaintiff must establish subject matter jurisdiction.
McKenzie,
123 F.3d at 938. We may affirm the district court’s dismissal for lack of subject matter jurisdiction on any grounds supported by the record.
Southwest Williamson Cty. Cmty. Ass’n, Inc. v. Slater,
173 F.3d 1033, 1036 (6th Cir.1999).
The False Claims Act “provide[s] for restitution to the government of money taken from it by fraud.”
United States ex rel. Augustine v. Century Health Services, Inc.,
289 F.3d 409, 413 (6th Cir.2002) (quoting
United States ex rel. Marcus v. Hess,
317 U.S. 537, 551, 63 S.Ct. 379, 87 L.Ed. 443 (1943)). Under the Act’s
qui tam
provisions, a private individual may bring a civil action on behalf of the United States against persons who knowingly submit false or fraudulent claims to the government for payment in violation of 31 U.S.C. § 3729(a).
See
31 U.S.C. §§ 3730(b)(d). Before proceeding with the suit, a
qui tam
plaintiff must disclose to the government the information on which his or her claim is based. 31 U.S.C. § 3730(b)(2). If the government chooses to intervene in the action, it assumes the role of lead prosecutor.
Id.;
31 U.S.C. § 3730(b)(4)(A), (c)(1). If the government declines to intervene, the
qui tam
Free access — add to your briefcase to read the full text and ask questions with AI
OPINION
JOHN R. GIBSON, Circuit Judge.
Relator Jeff Walburn appeals the district court’s dismissal of his
qui tam
action brought under the False Claims Act, 31 U.S.C. §§ 3729-33. Walburn’s suit alleges
that defendant Lockheed Martin altered and submitted false documents for compensation and incentive payments under its agreement with the United States to operate the Portsmouth Gaseous Diffusion Plant in Piketon, Ohio. The district court dismissed the action under the first-to-file bar of 31 U.S.C. § 3730(b)(5). We affirm the dismissal.
Relator Walburn alleges that he was employed as a security officer at the Portsmouth Plant, patrolling areas of the plant used to enrich uranium and store nuclear materials. The plant is owned by the United States and leased by the United States Enrichment Corporation, an entity created by Congress under the Energy Policy Act of 1992, 42 U.S.C. § 2297 (repealed). Lockheed enriches uranium for commercial and national defense purposes at the plant pursuant to a contract with the United States. Walburn alleges that federal law required Lockheed to maintain accreditation with the Department of Energy in order to conduct these operations. Beginning in 1981, employees at the plant were required to wear thermoluminescent dosimeters that would mechanically measure individual doses of radiation exposure. As a condition of its Department of Energy accreditation, Lockheed was required to keep records of the dosimeter readings together with a record of each employee’s dosage. Walburn alleges that after he was exposed to gases at the plant in 1994, Lockheed changed the recorded reading of his dosimeter, and that this was just one of at least 400 to 600 such changes Lockheed made to employees’ dosage readings each year. He alleges that Lockheed perpetrated this fraud in order to maintain its Department of Energy accreditation and continue to receive payments from the United States under its contract to operate the Portsmouth Plant.
On July 23, 1996, Walburn filed a multicount action against Lockheed seeking compensatory and punitive damages as a result of his exposure to gases at the Portsmouth Plant. Walburn sought relief in federal court on theories of (1) breach of contract, (2) civil rights violations under 42 U.S.C. §• 1983, (3) intentional tort, and (4) loss of consortium. On July 16, 1997, the district court entered an order dismissing the action. On May 25, 2000, Walburn filed the present
qui tarn
action under seal with the United States Department of Justice, alleging that Lockheed’s falsification of the dosage readings violated § 3729(a) of the False Claims Act.
See
31 U.S.C. § 3730(b)(2). Following an investigation into Walburn’s allegations, the United States declined to intervene.
Id.;
31 U.S.C. § 3730(b)(4)(B). Walburn elected to prosecute the action himself, and on November 12, 2002, the action was unsealed.
See
31 U.S.C. § 3730(b)(4)(B). Reviewing Lockheed’s motion to dismiss, the district court concluded that Walburn’s allegations were encompassed by the allegations in
United States ex rel Kenneth Brooks v. Lockheed Martin Corp., et al.,
No. Civ. L-00-1088, 2005 WL 841997, filed in the District of Maryland on April 24, 2000. Because the
Brooks
complaint was filed first, the district court dismissed Walburn’s action for lack of subject matter jurisdiction under the first-to-file bar of 31 U.S.C. § 3730(b)(5).
United States ex rel. Walburn v. Lockheed Martin Corp.,
312 F.Supp.2d 936, 940-41 (S.D.Ohio 2004). Walburn appeals the dismissal. 28 U.S.C. § 1291.
I.
We review de novo the dismissal of an action under the False Claims Act for lack of subject matter jurisdiction.
United States ex rel. McKenzie v. Bell-South Telecommunications, Inc.,
123 F.3d 935, 938 (6th Cir.1997);
see also United
States ex rel Lujan v. Hughes Aircraft Co.,
243 F.3d 1181, 1187 (9th Cir.2001);
Minnesota Ass’n of Nurse Anesthetists v. Allina Health System Corp.,
276 F.3d 1032, 1040 (8th Cir.2002). Because federal courts are courts of limited jurisdiction, the plaintiff must establish subject matter jurisdiction.
McKenzie,
123 F.3d at 938. We may affirm the district court’s dismissal for lack of subject matter jurisdiction on any grounds supported by the record.
Southwest Williamson Cty. Cmty. Ass’n, Inc. v. Slater,
173 F.3d 1033, 1036 (6th Cir.1999).
The False Claims Act “provide[s] for restitution to the government of money taken from it by fraud.”
United States ex rel. Augustine v. Century Health Services, Inc.,
289 F.3d 409, 413 (6th Cir.2002) (quoting
United States ex rel. Marcus v. Hess,
317 U.S. 537, 551, 63 S.Ct. 379, 87 L.Ed. 443 (1943)). Under the Act’s
qui tam
provisions, a private individual may bring a civil action on behalf of the United States against persons who knowingly submit false or fraudulent claims to the government for payment in violation of 31 U.S.C. § 3729(a).
See
31 U.S.C. §§ 3730(b)(d). Before proceeding with the suit, a
qui tam
plaintiff must disclose to the government the information on which his or her claim is based. 31 U.S.C. § 3730(b)(2). If the government chooses to intervene in the action, it assumes the role of lead prosecutor.
Id.;
31 U.S.C. § 3730(b)(4)(A), (c)(1). If the government declines to intervene, the
qui tam
plaintiff may serve the complaint on the defendant and proceed with the action on its own. 31 U.S.C. § 3730(b)(4)(B). As an incentive to bring such claims, private plaintiffs suing on behalf of the government receive a portion of the funds recovered in a successful suit.
See
31 U.S.C. § 3730(d).
The history of the False Claims Act’s
qui tam
provisions demonstrates repeated attempts by Congress to balance two competing policies.
McKenzie,
123 F.3d at 938 (discussing legislative history);
United States ex rel. Springfield Terminal Ry. Co. v. Quinn,
14 F.3d 645, 649-51 (D.C.Cir.1994) (same). On the one hand, the
qui tam
provisions seek to encourage “whistleblowers to act as private attorneys-general” in bringing suits for the common good.
See United States ex rel. Taxpayers Against Fraud v. General Elec. Co.,
41 F.3d 1032, 1041-42 (6th Cir.1994). On the other, the provisions seek to discourage opportunistic plaintiffs from bringing parasitic lawsuits whereby would-be relators merely feed off a previous disclosure of fraud.
United States ex rel. Jones v. Horizon Healthcare Corp.,
160 F.3d 326, 335 (6th Cir.1998) (citing
McKenzie,
123 F.3d at 942-943). To further the latter policy, Congress has placed a number of jurisdictional limitations on
qui tam
actions, two of which are relevant here: the fírst-to-file bar of 31 U.S.C. § 3730(b)(5) and the public disclosure bar of 31 U.S.C. § 3730(e)(4)(A). Under these provisions, if Walburn’s
qui tam
action was based upon information previously made public or if the claim had already been filed by another, the district court was required to dismiss the action.
Taxpayers Against Fraud,
41 F.3d at 1035. We address the application of each provision in turn.
II.
The district court dismissed Walburn’s action based on 81 U.S.C. § 3730(b)(5), concluding that the allegations contained in an earlier complaint filed against Lockheed by relator Brooks “encompassed” the allegations of Walburn’s complaint. Section 3730(b)(5) provides:
When a person brings a
[qui tam
action], no person other than the Government may intervene or bring a related action based on the facts underlying the pending action.
By its terms, this section “unambiguously establishes a first-to-file bar, preventing successive plaintiffs from bringing related actions based on the same underlying-facts.”
United States ex rel. Lujan v. Hughes Aircraft Co.,
243 F.3d 1181, 1187 (9th Cir.2001);
see also United States ex rel. LaCorte v. SmithKline Beecham Clinical Labs., Inc.,
149 F.3d 227, 232 (3d Cir. 1998). The first-to-file bar furthers the policy of the False Claims Act in that “[t]he first-filed claim provides the government notice of the essential facts of an alleged fraud, while the first-to-file bar stops repetitive claims.”
Lujan,
243 F.3d at 1187 (citing
LaCorte,
149 F.3d at 233-34 (discussing legislative history)).
In deciding whether Walburn’s action runs afoul of this bar, we compare his complaint with that in
Brooks.
See La Corte,
149 F.3d at 234. If both allege “all the essential facts” of the underlying fraud, the earlier-filed
Brooks
action bars Walburn’s action, even if Walburn’s complaint “incorporates somewhat different details.”
Id.
at 232-33;
Grynberg v. Koch Gateway Pipeline Co.,
390 F.3d 1276, 1279 (10th Cir.2004);
United States ex rel. Hampton v. Columbia/HCA Healthcare Corp.,
318 F.3d 214, 217-18 (D.C.Cir.2003);
Lujan,
243 F.3d at 1189. Both complaints allege that Lockheed defrauded the government in violation of the False Claims Act.
The
Brooks
relator alleges that Lockheed “falsified, concealed and destroyed documentation” relating to “plant management and operations” and knowingly submitted these “false records and statements” to the government, all in an effort to fraudulently induce government payment under Lockheed’s contract to operate the Portsmouth Plant. Walburn alleges that Lockheed maintained its Department of Energy accreditation by “knowingly concealing” its practice of “assigning] dosages to a person that differed from the dosages that were read from the [dosimeter] that the same person was wearing,” and then “used the [Department of Energy] accreditation, which had been falsely or fraudulently obtained ... to receive payments under the operating agreements for [the Portsmouth Plant].”
In comparing the two complaints, the district court concluded that the broad
fraudulent scheme alleged in the
Brooks
complaint “encompassed” the specific subset of fraud regarding the falsification of radiation dosage readings alleged by Wal-burn. The district court’s conclusion, although undoubtedly correct, is ultimately unremarkable, as the same could be said for any
qui tam
action alleging fraud in connection with any aspect of Lockheed’s operation of the Portsmouth Plant to have the misfortune of following behind the vague and broad-ranging allegations of fraud contained in the
Brooks
complaint. However, the recognition that the haystack of fraud set forth in
Brooks
’ complaint, may, as a literal matter, be said to “encompass” the needle of the specific fraud Walburn seeks to bring to the government’s attention, does not answer the question before us: whether such a vague and broadly-worded complaint should be given preemptive effect under § 3730(b)(5).
Walburn argues that the
Brooks
complaint should not be given preemptive effect under the first-to-file rule because its allegations are so fatally broad as to run afoul of the heightened pleading requirements for fraud under Federal Rule Civil Procedure 9(b). Although not expressly required by the statutory language, we have previously held that a complaint alleging violations of the False Claims Act must allege the circumstances surrounding the fraud with particularity required by Rule 9(b).
United States rel. Bledsoe v. Cmty. Health Sys., Inc.,
F.3d 634, 641-43 (6th Cir.2003);
see also Yuhasz v. Brush Wellman, Inc.,
341 F.3d 559, 562-63 (6th Cir.2003). We
based
this conclusion on the False Claims Act’s anti-fraud purpose as demonstrated by its text and accompanying legislative history.
See Bledsoe,
342 F.3d at 641-43. “In complying with Rule 9(b), a plaintiff, at a minimum, must ‘allege the time, place, and content of the alleged misrepresentation on which he or she relied; the fraudulent scheme; the fraudulent intent of the defendants; and the injury resulting from the fraud.’ ”
Id.
at 643 (quoting
Coffey v. Foamex L.P.,
2 F.3d 157, 161-62 (6th Cir.1993));
accord LaCorte,
149 F.3d at 234 (“Federal Rule of Civil Procedure 9(b) requires plaintiffs to plead fraud with particularity, specifying the time, place and substance of the defendant’s alleged conduct.”).
Here, the broad and conclusory allegations of the
Brooks
complaint are legally insufficient under Rule 9(b) because they fail to provide “the time, place, and content” of any allegedly fraudulent claim submitted to the government. The
Brooks
allegations merely set forth that “documents” and “records” relating to the management and operation of the plant were falsified, without specifying the nature of the alleged falsifications. Furthermore, the complaint neither identifies which of the named defendants actually submitted falsified “documents” and “records” to the government, nor which “documents” and “records” contained misrepresentations upon which the government relied. Thus, the
Brooks
complaint’s failure to comply with Rule 9(b) rendered it legally infirm from its inception, and therefore it cannot preempt Walburn’s action under the first-to-file bar.
Lockheed argues that, notwithstanding the breadth of the
Brooks
allegations, a holding that only a complaint that complies with Rule 9(b) can have preemptive effect under § 3730(b)(5) carves out an exception from the “exception-free” first-to-fíle bar that undermines its policy of discouraging parasitic suits.
See Lujan,
243 F.3d at 1187. However, we fail to see how according preemptive effect to a fatally-broad complaint furthers the policy of encouraging whistleblowers to notify the government of potential frauds.
See id.
A complaint that is insufficient under Rule 9(b) is dismissed precisely because it fails to provide adequate notice to the defendant of the fraud it alleges.
See Bledsoe,
342 F.3d at 643 (requiring a complaint alleging fraud to provide fair notice to defendants to enable them to “prepare an informed pleading responsive to the specific allegations of fraud.”). A complaint that fails to provide adequate notice to a defendant can hardly be said to have given the government notice of the essential facts of a fraudulent scheme, and therefore would not enable the government to uncover related frauds.
LaCorte,
149 F.3d at 234. Indeed, we have previously recognized that it is precisely the heightened pleading requirement of Rule 9(b) that deters would-be relators
from
making “overly broad allegations” that fail to adequately alert the government to possible fraud in an effort to preclude future relators from sharing in any bounty eventually recovered.
Bledsoe,
342 F.3d at 642 (quoting
LaCorte,
149 F.3d at 234).
While there is no indication that the
Brooks
relator worded his complaint in excessively general terms in order to preserve the lion’s share of any potential recovery for himself, his broad allegations nonetheless fail to set forth the facts underlying the fraud he alleges as required by Rule 9(b). Walburn’s action cannot be “based on the facts underlying” the
Brooks
action when the facts necessary to put the government on notice of the fraud alleged are conspicuously absent from the
Brooks
complaint. Because the
Brooks
action is legally infirm under Rule 9(b), it fails to preempt Walburn’s later-filed action despite the fact that the overly-broad allegations of the
Brooks
complaint “encompass” the specific allegations of fraud made by Walburn.
III.
While the
qui tam
provisions of the False Claims Act are designed to encourage corporate whistleblowers, a “relator must be a true ‘whistleblower’ ” in order to bring suit.
United States ex rel. Taxpayers Against Fraud v. General Elec. Co.,
41 F.3d 1032, 1035 (6th Cir.1994). To that end, § 3730(e)(4) limits the subject matter jurisdiction of federal courts over
qui tam
actions based upon previously disclosed information.
United States ex rel. McKenzie v. BellSouth Telecommunications, Inc.,
123 F.3d 935, 938 (6th Cir. 1997). Specifically, the “public disclosure” bar provides:
(4)(A)No court shall have jurisdiction over an action under this section based
upon the public disclosure of allegations or transactions in a criminal, civil, or administrative hearing, in a congressional, administrative, or Government Accounting Office report, hearing, audit, or investigation, or from the news media, unless the action is brought by the Attorney General or the person bringing the action is an original source of the information.
(B) For purposes of this paragraph, “original source” means an individual who has direct and independent knowledge of the information on which the allegations are based and has voluntarily provided the information to the Government before filing an action under this section which is based on the information.
31 U.S.C. § 3730(e)(4).
In determining whether the jurisdictional bar of § 3730(e)(4) applies to a relator’s case, we consider: “(A) whether there has been a public disclosure; (B) of the allegations or transactions that form the basis of the relator’s complaint; and (C) whether the relator’s action is ‘based upon’ the publicly disclosed allegations or transactions.”
United States ex rel. Jones v. Horizon Healthcare Corp.,
160 F.3d 326, 330 (6th Cir.1998);
see also A.D. Roe Co.,
186 F.3d at 721-23. If the answer is “no” to any of these questions, the inquiry ends, and the
qui tam
action may proceed; however, if the answer to each of the above questions is “yes,” then we must determine whether the relator nonetheless qualifies as an “original source” under § 3730(e)(4)(B), in which case the suit may proceed.
Jones,
160 F.3d at 330.
We have no trouble concluding that Wal-burn’s 1996 complaint in his civil action against Lockheed qualifies as a “public disclosure.” The plain language of § 3730(e)(4) includes as a public disclosure the dissemination of information through a “civil hearing.” We have interpreted “civil hearing” to include court filings generally, and “a plaintiffs complaint” specifically.
McKenzie,
123 F.3d at 939;
Jones,
160 F.3d at 331. In order to determine whether Walburn’s 1996 complaint disclosed the “allegations and transactions” forming the basis of his later-filed
qui tam
action we must compare the allegations of the two complaints. As discussed previously, Wal-burn’s
qui tam
action alleges that Lockheed falsified dosage readings obtained from thermoluminescent dosimeters in order to maintain its accreditation and receive payments from the United States under its contract to operate the Portsmouth Plant. In his 1996 suit Walburn alleged,
inter alia:
16. To alert these [Defendants’] employees to any such radiation exposure, certain employees are required to submit urinalysis periodically and there is a dosimeter program. The dosimeter program consists of a monitoring badge that registers an employee’s dose exposure to radiation. Certain employees are also required to submit to bioassay urinalysis to detect exposure to various gasses.
17. Defendants periodically collect the monitoring badges from each individual employee, records any dosage readings from each individual badge, and maintains records of these dosages.
19. Defendants altered and/or destroyed its dosimeter records on the amount of radiation Plaintiff Jeff Wal-burn was exposed to while an employee of Defendants.
33. Defendants have failed to perform their obligations and duties under said contract, including but not limited to:
a) Altering and destroying results of employees [sic] radiation exposure in the dosimeter program ...
38. Defendant, by intentionally altering Plaintiffs radiation records and medical records, had violated 10 CFR Part 19 and specifically § 19.12 and 19.13; 29 CFR § 1910.96 and 1910.97; 48 CFR § 952.223-75, § 970.23 et Seq., and § 970.52.
39. This violation of federal law ...
We have previously held that the “allegations and transactions” forming the basis of a
qui tam
have been disclosed “when enough information exists in the public domain to expose the fraudulent transaction or the allegation of fraud.”
Jones,
160 F.3d at 331. When the “misrepresented state of facts and a true state of facts” have been disclosed, there is enough information in the public domain to give rise to “an inference of impropriety.”
Id.
at 332 (citing
United States ex rel. Springfield Terminal Ry. Co. v. Quinn,
14 F.3d 645, 655 (D.C.Cir.1994)). As in
Jones,
although Walburn’s 1996 suit “may not have constituted an explicit, formal allegation of either fraud or the essential elements of fraud, it certainly presented enough facts to create an inference of wrongdoing on the part of [Lockheed].”
Id.
The 1996 complaint disclosed both the misrepresented state of facts: the falsified dosage readings submitted to the government, as well as the "true state of facts: the actual dosimeter readings. The allegations of falsified dosage readings in violation of federal law gives rise to an inference of impropriety on the part of Lockheed in its operation of the Portsmouth Plant, and thus effectively alerted the public to the fraud later alleged in Walburn’s
qui tam
action.
Furthermore, we conclude that Wal-burn’s
qui tam
action is “based upon” the allegations and transactions disclosed in his 1996 suit. In line with the reasoning of the majority of circuits, we have construed “based upon” broadly to mean “supported by” information previously disclosed.
McKenzie,
123 F.3d at 940;
Bledsoe,
342 F.3d at 646;
A.D. Roe,
186 F.3d at 725;
Jones,
160 F.3d at 332. Walburn’s present action is “supported by” the same alleged falsification of dosage readings alleged in his 1996 suit. To be sure, Walburn’s
qui tam
action provides greater detail regarding the falsification of the dosimeter readings than did his 1996 complaint. However, these additional details are insufficient to avoid our broad construction of the public disclosure bar, which precludes individuals who base
any part
of their allegations on publicly disclosed information from bringing a later
qui tam
action.
McKenzie,
123 F.3d at 940;
Bledsoe,
342 F.3d at 646;
A.D. Roe,
186 F.3d at 725;
Jones,
160 F.3d at 332.
Because we conclude that Walburn’s
qui tam
action is based upon allegations and transactions publicly disclosed in his 1996 suit, Walburn must qualify as an “original source” to maintain his suit. 31 U.S.C. § 3730(e)(4)(A) and (B);
see also AD. Roe,
186 F.3d at 725 n. 7. An “original source” is “an individual who has direct and independent knowledge of the information on which the allegations are based and has voluntarily provided the information to the Government
before
filing an action under this section which is based on the information.” 31 U.S.C. § 3730(e)(4)(B) (emphasis added). Under the law of this Circuit, the individual must have provided the government with the information
prior to any public disclosure
to qualify as an “original source.”
McKenzie,
123 F.3d at 942 (adopting the approach
of United States ex rel. Findley v. FPC-Boron Employees’ Club,
105 F.3d 675, 690 (D.C.Cir.1997)). Here, Walburn filed his 1996 action long
before he filed his sealed
qui tam
action with the government on May 25, 2000. Walburn’s failure to report his allegations of fraud to the federal government before filing his 1996 suit precludes him from enjoying original source status. Jones, 160 F.3d at 335 n. 7. Thus, his
qui tam
action is barred under 31 U.S.C. § 3730(e)(4).
IV.
Because the district court lacked jurisdiction under 31 U.S.C. § 3730(e)(4), its dismissal of Walburn’s complaint is affirmed.